Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 49

1.

Detection of high mobility group A2 specific mRNA in the plasma of patients affected by epithelial ovarian cancer.

Galdiero F, Romano A, Pasquinelli R, Pignata S, Greggi S, Vuttariello E, Bello AM, Calise C, Scaffa C, Pisano C, Losito NS, Fusco A, Califano D, Chiappetta G.

Oncotarget. 2015 Feb 12. [Epub ahead of print]

2.

The anti-apoptotic BAG3 protein is expressed in lung carcinomas and regulates small cell lung carcinoma (SCLC) tumor growth.

Chiappetta G, Basile A, Barbieri A, Falco A, Rosati A, Festa M, Pasquinelli R, Califano D, Palma G, Costanzo R, Barcaroli D, Capunzo M, Franco R, Rocco G, Pascale M, Turco MC, De Laurenzi V, Arra C.

Oncotarget. 2014 Aug 30;5(16):6846-53.

3.

The multifaceted roles of Bcl11b in thymic and peripheral T cells: impact on immune diseases.

Avram D, Califano D.

J Immunol. 2014 Sep 1;193(5):2059-65. doi: 10.4049/jimmunol.1400930. Review.

PMID:
25128552
4.

Diverting T helper cell trafficking through increased plasticity attenuates autoimmune encephalomyelitis.

Califano D, Sweeney KJ, Le H, VanValkenburgh J, Yager E, O'Connor W Jr, Kennedy JS, Jones DM, Avram D.

J Clin Invest. 2014 Jan;124(1):174-87. doi: 10.1172/JCI70103. Epub 2013 Dec 9.

5.

High HMGA2 expression and high body mass index negatively affect the prognosis of patients with ovarian cancer.

Califano D, Pignata S, Losito NS, Ottaiano A, Greggi S, De Simone V, Cecere S, Aiello C, Esposito F, Fusco A, Chiappetta G.

J Cell Physiol. 2014 Jan;229(1):53-9. doi: 10.1002/jcp.24416.

PMID:
23765903
6.

A microRNA signature defines chemoresistance in ovarian cancer through modulation of angiogenesis.

Vecchione A, Belletti B, Lovat F, Volinia S, Chiappetta G, Giglio S, Sonego M, Cirombella R, Onesti EC, Pellegrini P, Califano D, Pignata S, Losito S, Canzonieri V, Sorio R, Alder H, Wernicke D, Stoppacciaro A, Baldassarre G, Croce CM.

Proc Natl Acad Sci U S A. 2013 Jun 11;110(24):9845-50. doi: 10.1073/pnas.1305472110. Epub 2013 May 22.

7.

BAG3 down-modulation reduces anaplastic thyroid tumor growth by enhancing proteasome-mediated degradation of BRAF protein.

Chiappetta G, Basile A, Arra C, Califano D, Pasquinelli R, Barbieri A, De Simone V, Rea D, Giudice A, Pezzullo L, De Laurenzi V, Botti G, Losito S, Conforti D, Turco MC.

J Clin Endocrinol Metab. 2012 Jan;97(1):E115-20. doi: 10.1210/jc.2011-0484. Epub 2011 Nov 9.

PMID:
22072743
8.

miR-191 down-regulation plays a role in thyroid follicular tumors through CDK6 targeting.

Colamaio M, Borbone E, Russo L, Bianco M, Federico A, Califano D, Chiappetta G, Pallante P, Troncone G, Battista S, Fusco A.

J Clin Endocrinol Metab. 2011 Dec;96(12):E1915-24. doi: 10.1210/jc.2011-0408. Epub 2011 Sep 28.

PMID:
21956418
9.

Critical role of Bcl11b in suppressor function of T regulatory cells and prevention of inflammatory bowel disease.

Vanvalkenburgh J, Albu DI, Bapanpally C, Casanova S, Califano D, Jones DM, Ignatowicz L, Kawamoto S, Fagarasan S, Jenkins NA, Copeland NG, Liu P, Avram D.

J Exp Med. 2011 Sep 26;208(10):2069-81. doi: 10.1084/jem.20102683. Epub 2011 Aug 29.

10.

Transcription factor Bcl11b controls selection of invariant natural killer T-cells by regulating glycolipid presentation in double-positive thymocytes.

Albu DI, VanValkenburgh J, Morin N, Califano D, Jenkins NA, Copeland NG, Liu P, Avram D.

Proc Natl Acad Sci U S A. 2011 Apr 12;108(15):6211-6. doi: 10.1073/pnas.1014304108. Epub 2011 Mar 28.

11.

Flow cytometry analysis of transcription factors in T lymphocytes.

Albu DI, Califano D, Avram D.

Methods Mol Biol. 2010;647:377-90. doi: 10.1007/978-1-60761-738-9_23.

12.

Antigen-specific clonal expansion and cytolytic effector function of CD8+ T lymphocytes depend on the transcription factor Bcl11b.

Zhang S, Rozell M, Verma RK, Albu DI, Califano D, VanValkenburgh J, Merchant A, Rangel-Moreno J, Randall TD, Jenkins NA, Copeland NG, Liu P, Avram D.

J Exp Med. 2010 Aug 2;207(8):1687-99. doi: 10.1084/jem.20092136. Epub 2010 Jul 26.

13.

FEZ1/LZTS1 protein expression in ovarian cancer.

Califano D, Pignata S, Pisano C, Greggi S, Laurelli G, Losito NS, Ottaiano A, Gallipoli A, Pasquinelli R, De Simone V, Cirombella R, Fusco A, Chiappetta G.

J Cell Physiol. 2010 Feb;222(2):382-6. doi: 10.1002/jcp.21962.

PMID:
19885841
14.

BCL11B enhances TCR/CD28-triggered NF-kappaB activation through up-regulation of Cot kinase gene expression in T-lymphocytes.

Cismasiu VB, Duque J, Paskaleva E, Califano D, Ghanta S, Young HA, Avram D.

Biochem J. 2009 Jan 15;417(2):457-66. doi: 10.1042/BJ20080925.

15.

HMGA2 mRNA expression correlates with the malignant phenotype in human thyroid neoplasias.

Chiappetta G, Ferraro A, Vuttariello E, Monaco M, Galdiero F, De Simone V, Califano D, Pallante P, Botti G, Pezzullo L, Pierantoni GM, Santoro M, Fusco A.

Eur J Cancer. 2008 May;44(7):1015-21. doi: 10.1016/j.ejca.2008.02.039. Epub 2008 Mar 28.

PMID:
18375116
16.

Loss of p27 expression through RAS-->BRAF-->MAP kinase-dependent pathway in human thyroid carcinomas.

Motti ML, De Marco C, Califano D, De Gisi S, Malanga D, Troncone G, Persico A, Losito S, Fabiani F, Santoro M, Chiappetta G, Fusco A, Viglietto G.

Cell Cycle. 2007 Nov 15;6(22):2817-25. Epub 2007 Aug 13.

17.

Overexpression of the S-phase kinase-associated protein 2 in thyroid cancer.

Chiappetta G, De Marco C, Quintiero A, Califano D, Gherardi S, Malanga D, Scrima M, Montero-Conde C, Cito L, Monaco M, Motti ML, Pasquinelli R, Agosti V, Robledo M, Fusco A, Viglietto G.

Endocr Relat Cancer. 2007 Jun;14(2):405-20.

18.

Design, synthesis, and cytotoxic evaluation of a new series of 3-substituted spiro[(dihydropyrazine-2,5-dione)-6,3'-(2',3'-dihydrothieno[2,3-b]naphtho-4',9'-dione)] derivatives.

Gomez-Monterrey I, Campiglia P, Carotenuto A, Califano D, Pisano C, Vesci L, Lama T, Bertamino A, Sala M, di Bosco AM, Grieco P, Novellino E.

J Med Chem. 2007 Apr 19;50(8):1787-98. Epub 2007 Mar 22.

PMID:
17375902
19.

Significance of erb-B2 immunoreactivity in cervical cancer.

Califano D, Losito S, Pisano C, Santelli G, Greggi S, Iodice F, DiVagno G, Silvestro G, Tambaro R, Formato R, Iaffaioli VR, Di Maio M, Pignata S.

Front Biosci. 2006 Sep 1;11:2071-6.

PMID:
16720293
20.

Synthesis, pharmacological evaluation, and molecular modeling studies of novel peptidic CAAX analogues as farnesyl-protein-transferase inhibitors.

Santagada V, Caliendo G, Severino B, Lavecchia A, Perissutti E, Fiorino F, Zampella A, Sepe V, Califano D, Santelli G, Novellino E.

J Med Chem. 2006 Mar 23;49(6):1882-90.

PMID:
16539374
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk